FABP1 and cancer: Expression is reduced in adenomas and poorly differentiated cancers; significantly downregulated in MSI and medullary carcinomas. IFNγ downregulates FABP1 expression, while PPARγ activation restores it, suggesting a regulatory loop between inflammatory signalling and lipid metabolism.